2% of blood samples collected in California in December 13-16th, 2019 analyzed in this study had antibodies reactive to SARS-CoV-2. It’s possible some are due to cross reactivity of antibodies from other corona viruses but not likely that all were.
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1785/6012472
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1785/6012472
Antibody development (especially IgG) lags SARS-CoV-2 infection, so it seems likely that the virus was here as early as late November.
The tests found IgM antibodies as well, which indicates active or recently active infection among those donating blood in December.
The tests found IgM antibodies as well, which indicates active or recently active infection among those donating blood in December.